𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Periurethral prostatic duct carcinoma. Clinical features and treatment results

✍ Scribed by Gene Kopelson; Leon Harisiadis; Nicholas A. Romas; Ralph J. Veenema; Myron Tannenbaum

Publisher
John Wiley and Sons
Year
1978
Tongue
English
Weight
856 KB
Volume
42
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Salivary duct carcinoma: Clinical charac
Salivary duct carcinoma: Clinical characteristics and treatment strategies
✍ Marco Guzzo; Silvana Di Palma; Cesare Grandi; Roberto Molinari πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 458 KB πŸ‘ 3 views

Background: Salivary duct carcinoma (SDC) is a widely recognized only recently by pathologists, highly malignant tumor of the salivary gland. as reflected by the increasing clinicopathologic Methods: Twenty-six cases observed during the period 1975 to 1994 were selected from the pathology archives o

Cryosurgery as a treatment for prostate
Cryosurgery as a treatment for prostate carcinoma : Results and complications
✍ Wilson S. Wong; Douglas O. Chinn; Mahlon Chinn; James Chinn; Wynnyee L. Tom; Wyn πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 739 KB

## Background: There has been a resurgence of interest in cryosurgical ablation of the prostate for the treatment of carcinoma. this is due to recent advances in cryosurgical technology, which have resulted in relatively lower morbidity. the objective of this study was to evaluate the effectiveness

Patient satisfaction with treatment deci
Patient satisfaction with treatment decisions for clinically localized prostate carcinoma. Results from the Prostate Cancer Outcomes Study
✍ Richard M. Hoffman; William C. Hunt; Frank D. Gilliland; Robert A. Stephenson; A πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 93 KB πŸ‘ 1 views

## Abstract ## BACKGROUND Men with early‐stage prostate carcinoma can choose aggressive treatment or conservative management. The authors used data from a population‐based cohort of men with clinically localized prostate carcinoma to describe satisfaction with treatment decisions 24 months after d